{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:28:49Z","timestamp":1793600929313,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22321005"],"award-info":[{"award-number":["22321005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308000"],"award-info":[{"award-number":["2023YFC2308000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cbpa.2026.102716","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:41:20Z","timestamp":1781811680000},"page":"102716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recent advances in glycoconjugate-based therapeutics"],"prefix":"10.1016","volume":"93","author":[{"given":"Yuankun","family":"Dao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-4344","authenticated-orcid":false,"given":"Suwei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2026.102716_bib1","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.cell.2022.06.016","article-title":"Tools for mammalian glycoscience research","volume":"185","author":"Griffin","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2026.102716_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-biochem-030122-044347","article-title":"Reading and writing the human glycocode","volume":"93","author":"de Haan","year":"2024","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cbpa.2026.102716_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.cbpa.2026.102716_bib4","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","article-title":"Glycoconjugates: synthesis, functional studies, and therapeutic developments","volume":"122","author":"Shivatare","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122689","article-title":"Glycoconjugates: advances in modern medicines and human health","volume":"348","author":"Chettri","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.cbpa.2026.102716_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2026.102716_bib7","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1021\/acs.chemrev.8b00238","article-title":"Chemoenzymatic methods for the synthesis of glycoproteins","volume":"118","author":"Li","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib8","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1021\/acs.chemrev.2c00021","article-title":"Synthetic glycans to improve current glycoconjugate vaccines and fight antimicrobial resistance","volume":"122","author":"Del Bino","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2021.01.021","article-title":"Chemical (neo)glycosylation of biological drugs","volume":"171","author":"Walther","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102420","article-title":"Recent advances in antibody glycoengineering for the gain of functions","volume":"78","author":"Liu","year":"2024","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib11","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1021\/acs.chemrev.0c01210","article-title":"Discovery of semi and fully synthetic carbohydrate vaccines against bacterial infections using a medicinal chemistry approach","volume":"121","author":"Seeberger","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib12","doi-asserted-by":"crossref","first-page":"cwae092","DOI":"10.1093\/glycob\/cwae092","article-title":"Glycoconjugate vaccines: platforms and adjuvants for directed immunity","volume":"34","author":"Lensch","year":"2024","journal-title":"Glycobiology"},{"key":"10.1016\/j.cbpa.2026.102716_bib13","article-title":"Conjugation methods in synthetic glycoconjugate vaccines","volume":"4","author":"Huang","year":"2024","journal-title":"Chem Mater"},{"key":"10.1016\/j.cbpa.2026.102716_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108158","article-title":"Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics","volume":"235","author":"Sorieul","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cbpa.2026.102716_bib15","doi-asserted-by":"crossref","first-page":"35356","DOI":"10.1021\/jacs.4c13972","article-title":"Semisynthetic glycoconjugate vaccine lead against Klebsiella pneumoniae serotype O2afg induces functional antibodies and reduces the burden of acute Pneumonia","volume":"146","author":"Shen","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_sref16","doi-asserted-by":"crossref","first-page":"eaea8116","DOI":"10.1126\/sciadv.aea8116","article-title":"Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against Haemophilus influenzae type b","volume":"12","author":"Han","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.cbpa.2026.102716_bib17","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1021\/jacs.4c03179","article-title":"A fluorinated sialic acid vaccine lead against Meningitis B and C","volume":"146","author":"Jordan","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_bib18","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1038\/s41467-024-47457-4","article-title":"A comprehensive synthetic library of poly-N-acetyl glucosamines enabled vaccine against lethal challenges of Staphylococcus aureus","volume":"15","author":"Tan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102716_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148785","article-title":"Rhamno-oligosaccharide-based glycoconjugates as promising vaccine candidates against group A streptococcus","volume":"333","author":"Wang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cbpa.2026.102716_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108144","article-title":"Immunomodulatory glycomedicine: introducing next generation cancer glycovaccines","volume":"65","author":"Freitas","year":"2023","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cbpa.2026.102716_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.glycos.2025.100006","article-title":"A cancer vaccine based on N-linked sialyl-Tn antigen elicits robust and selective antitumor immunity","author":"Huo","year":"2025","journal-title":"Glycosci Ther"},{"key":"10.1016\/j.cbpa.2026.102716_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116619","article-title":"Tumor-associated carbohydrate antigens of MUC1 - Implication in cancer development","volume":"174","author":"Radziejewska","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cbpa.2026.102716_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202411009","article-title":"Non-natural MUC1 glycopeptide homogeneous cancer vaccine with enhanced immunogenicity and therapeutic activity","volume":"63","author":"Guerreiro","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2026.102716_sref24","article-title":"Chemoenzymatic synthesis of glycopeptide library decodes sialylation-dependent immunodominance to enable a potent multicomponent antitumor vaccine","volume":"138","author":"Wu","year":"2026","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2026.102716_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","article-title":"Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action","volume":"5","author":"Pifferi","year":"2021","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118223","article-title":"QS-21: structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants","volume":"301","author":"Hu","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41586-024-07345-9","article-title":"Complete biosynthesis of QS-21 in engineered yeast","volume":"629","author":"Liu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2026.102716_sref28","article-title":"Facile preparation of carbohydrate-containing adjuvants based on self-assembling glycopeptide conjugates","volume":"63","author":"Wang","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2026.102716_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ddtec.2020.11.006","article-title":"Recent advances in self-adjuvanting glycoconjugate vaccines","volume":"37","author":"Manabe","year":"2020","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.cbpa.2026.102716_bib30","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1021\/acs.jmedchem.4c01631","article-title":"Fully synthetic TF-Based self-adjuvanting vaccine simultaneously, triggers iNKT cells and mincle and protects mice against tumor development","volume":"67","author":"Yang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_sref31","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acschembio.4c00214","article-title":"A glycolipid-peptide-hapten tricomponent conjugate vaccine generates durable antihapten antibody responses in mice","volume":"19","author":"Pankhurst","year":"2024","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s43586-022-00128-4","article-title":"Glycoproteomics","volume":"2","author":"Bagdonaite","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.cbpa.2026.102716_bib33","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41467-024-47693-8","article-title":"Exposing the molecular heterogeneity of glycosylated biotherapeutics","volume":"15","author":"Schachner","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102716_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102405","article-title":"Recent advances in chemical synthesis of O-linked glycopeptides and glycoproteins: an advanced synthetic tool for exploring the biological realm","volume":"77","author":"Zhao","year":"2023","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.863118","article-title":"Strategies for glycoengineering therapeutic proteins","volume":"10","author":"Dammen-Brower","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib36","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1038\/s41467-020-17473-1","article-title":"An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles","volume":"11","author":"Madsen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102716_bib37","doi-asserted-by":"crossref","first-page":"eadx8201","DOI":"10.1126\/sciadv.adx8201","article-title":"Chemical synthesis uncovers the significant impact of natural glycosylation on islet amyloid polypeptide aggregation","volume":"11","author":"Li","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.cbpa.2026.102716_bib38","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.31635\/ccschem.025.202506085","article-title":"Chemical synthesis unveils extraordinary enhancement of glucagon-like Peptide-1 stability by natural glycosylation","volume":"8","author":"Li","year":"2026","journal-title":"CCS Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib39","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.apsb.2025.08.005","article-title":"Deciphering the significant impact of natural glycosylation on human insulin","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cbpa.2026.102716_sref40","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1021\/jacs.5c03757","article-title":"Total chemical synthesis of glucagon glycoforms reveals the remarkable influence of natural glycosylation","volume":"147","author":"Li","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_bib41","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1038\/s41467-025-60978-w","article-title":"An O-glycopeptide participates in the formation of distinct A\u03b242 fibril structures and attenuates A\u03b242 neurotoxicity","volume":"16","author":"Wei","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102716_sref42","article-title":"Glucuronidase-instructed glycopeptide self-assembly for selective killing of cancer cells through lysosomal membrane permeabilization","volume":"64","author":"Xu","year":"2025","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2026.102716_bib43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.xphs.2018.11.029","article-title":"The mechanistic impact of N-glycosylation on stability, pharmacokinetics, and immunogenicity of therapeutic proteins","volume":"108","author":"Zhou","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.cbpa.2026.102716_bib44","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1021\/acs.jmedchem.4c00093","article-title":"Engineering of a biologically active glycosylated glucagon-like Peptide-1 analog","volume":"67","author":"Chandrashekar","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib45","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1039\/D5SC01670C","article-title":"Rapid synthesis of glycosylated insulins by flow-based peptide synthesis","volume":"16","author":"Maki","year":"2025","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2026.102716_sref46","doi-asserted-by":"crossref","first-page":"34452","DOI":"10.1021\/jacs.4c11091","article-title":"Site-specific glyco-tagging of native proteins for the development of biologicals","volume":"146","author":"Gimeno","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_bib47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41589-022-01219-9","article-title":"Structure, sequon recognition and mechanism of tryptophan C-mannosyltransferase","volume":"19","author":"Bloch","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib48","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1021\/acscatal.5c07775","article-title":"Mechanism of bacterial arginine N-Glycosylation: a chemically challenging post-translational modification","volume":"16","author":"Piniello","year":"2026","journal-title":"ACS Catal"},{"key":"10.1016\/j.cbpa.2026.102716_bib49","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1021\/acs.jmedchem.5c01550","article-title":"Design, synthesis, and biological evaluation of arginine N-Glycosylation stapled peptides with potent antitumor activity in vivo","volume":"68","author":"Fu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib50","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/acs.jmedchem.4c02564","article-title":"Peptide double-stapling and arginine N-Glycosylation triggered the development of therapeutic antimicrobial peptides capable of killing drug-resistant bacteria in mice","volume":"68","author":"Li","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_sref51","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.1021\/jacs.4c18712","article-title":"Concept of future glycoprotein drugs: synthesis of a thioglycosidically linked \u03b1-N-Acetylgalactosamine-Carrying cyclic peptide as a model of miniature macrophage activating factor","volume":"147","author":"Kanzaki","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_sref52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41586-024-08042-3","article-title":"Glucose-sensitive insulin with attenuation of hypoglycemia","volume":"634","author":"Hoeg-Jensen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2026.102716_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody\u2013drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cbpa.2026.102716_bib54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/D4MD00637B","article-title":"Technical, preclinical, and clinical developments of fc-glycan-specific antibody\u2012drug conjugates","volume":"16","author":"Yang","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.cbpa.2026.102716_bib55","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1039\/D5CB00096C","article-title":"A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy","volume":"6","author":"Xue","year":"2025","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_sref56","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202518579","article-title":"Efficient preparation of homogenous antibody conjugates via Glycosite-Specific transglycosylation enabled by readily available glycosyl donors","volume":"65","author":"Cai","year":"2026","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.cbpa.2026.102716_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","article-title":"Extracellular targeted protein degradation: an emerging modality for drug discovery","volume":"23","author":"Wells","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2026.102716_bib58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chembiol.2026.01.008","article-title":"Lysosome-targeting chimeras enable targeted protein degradation","volume":"33","author":"Li","year":"2026","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2026.102716_bib60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_sref61","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417942","article-title":"A bifunctional lysosome-targeting chimera nanoplatform for tumor-selective protein degradation and enhanced cancer immunotherapy","volume":"37","author":"Xing","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.cbpa.2026.102716_bib62","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41467-024-46130-0","article-title":"A coassembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102716_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300643","article-title":"Development of integrin targeting chimeras (ITACs) for the lysosomal degradation of extracellular proteins","volume":"19","author":"Zhou","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbpa.2026.102716_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","article-title":"Transferrin receptor targeting chimeras for membrane protein degradation","volume":"638","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2026.102716_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106908","article-title":"Conjugation with glucagon like peptide-1 enables targeted protein degradation","volume":"141","author":"Zhu","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.cbpa.2026.102716_sref66","doi-asserted-by":"crossref","first-page":"17728","DOI":"10.1021\/jacs.4c02463","article-title":"Lysosome targeting chimeras for Glut1-Facilitated targeted protein degradation","volume":"146","author":"Luo","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_bib67","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acschembio.4c00584","article-title":"Glucose transporter-targeting chimeras enabling tumor-selective degradation of secreted and membrane proteins","volume":"19","author":"Yun","year":"2024","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2026.102716_bib68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.cbpa.2026.102716_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cbpa.2026.102716_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2026.102716_bib71","first-page":"486","article-title":"A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety","volume":"38","author":"Bae","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.cbpa.2026.102716_sref72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409569122","article-title":"Glycolipid nanoparticles target the spleen and detarget the liver without charge","volume":"122","author":"Gentry","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2026.102716_sref73","doi-asserted-by":"crossref","first-page":"41248","DOI":"10.1021\/jacs.5c16448","article-title":"Glycolipids substitute PEG lipids in lipid nanoparticles for mRNA delivery","volume":"147","author":"Jin","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102716_bib74","article-title":"PEG-Free monosialoganglioside lipid nanoparticles with spleen-selective mRNA delivery for cancer immunotherapy","volume":"36","author":"Wang","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.cbpa.2026.102716_bib75","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cell.2024.01.034","article-title":"Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries","volume":"187","author":"Tsai","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2026.102716_bib76","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1039\/D4SC01466A","article-title":"Nanopore-based glycan sequencing: state of the art and future prospects","volume":"15","author":"Yao","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2026.102716_bib77","doi-asserted-by":"crossref","first-page":"15971","DOI":"10.1021\/acs.chemrev.2c00110","article-title":"Glycoinformatics in the artificial intelligence era","volume":"122","author":"Bojar","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.cbpa.2026.102716_bib78","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.cell.2021.04.023","article-title":"Small RNAs are modified with N-glycans and displayed on the surface of living cells","volume":"184","author":"Flynn","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2026.102716_bib79","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.cell.2025.07.046","article-title":"Glycan shielding enables TCR-sufficient allogeneic CAR-T therapy","volume":"188","author":"Wu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2026.102716_bib80","article-title":"Antibody-lectin chimeras for glyco-immune checkpoint blockade","author":"Stark","year":"2025","journal-title":"Nat Biotechnol"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:54:34Z","timestamp":1793598874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593126000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"alternative-id":["S1367593126000657"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102716","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in glycoconjugate-based therapeutics","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102716"}}